NCT06309836 Retrospective and Prospective Observational Study in Patients With Advanced Basal Cell Carcinoma
| NCT ID | NCT06309836 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Societa Italiana di Dermatologia Medica, Chirurgica, Estetica e di Malattie Sessualmente Trasmesse |
| Condition | Basal Cell Carcinoma |
| Study Type | OBSERVATIONAL |
| Enrollment | 250 participants |
| Start Date | 2021-06-23 |
| Primary Completion | 2029-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 250 participants in total. It began in 2021-06-23 with a primary completion date of 2029-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Retrospective and Prospective Observational Study in Patients With Advanced Basal Cell Carcinoma.
Eligibility Criteria
Inclusion Criteria: 1. Male and female patients aged ≥ 18 years 2. Patients diagnosed with advanced basal cell carcinoma of the skin, i.e. tumours included in at least one of the following categories: locally advanced carcinoma (not radically treatable by surgery and/or radiotherapy), carcinoma with lymph node and/or distant metastatic localisation 3. patients who have had at least one access (first visit or follow-up visit) at the dermatology or oncology outpatient clinic of the centres involved * Patients diagnosed with advanced BCC who have accessed the centre from 1 January 2016 until the date of activation of the centre will be included in the retrospective cohort; * Patients diagnosed with advanced BCC who have accessed the centre from the date of activation 4. Signature of informed consent Exclusion Criteria: Patients incapable of giving informed consent
Contact & Investigator
Ketty MD Peris
PRINCIPAL INVESTIGATOR
IRCCS FONDAZIONE POLICLINICO GEMELLI
Frequently Asked Questions
Who can join the NCT06309836 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Basal Cell Carcinoma. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06309836 currently recruiting?
Yes, NCT06309836 is actively recruiting participants. Contact the research team at ketty.peris@unicatt.it for enrollment information.
Where is the NCT06309836 trial being conducted?
This trial is being conducted at Roma, Italy.
Who is sponsoring the NCT06309836 clinical trial?
NCT06309836 is sponsored by Societa Italiana di Dermatologia Medica, Chirurgica, Estetica e di Malattie Sessualmente Trasmesse. The principal investigator is Ketty MD Peris at IRCCS FONDAZIONE POLICLINICO GEMELLI. The trial plans to enroll 250 participants.